The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Group B Streptococcal Infections in Elderly Adults
Abstract
Elderly adults account for >40% of persons with invasive group B streptococcal (GBS) disease and for >50% of GBS-associated deaths in the United States. The prevalence of colonization among healthy elderly adults (approximately 25%) is similar to that among women of childbearing age. Delineating contributions of comorbid conditions, altered integrity of anatomical barriers, and abnormalities in immune responses caused by immune senescence to pathogenesis require further investigation. Delayed clinical recognition of illness may contribute to poor outcome. Skin and soft-tissue infections and bacteremia with no identified focus are common manifestations of infection in elderly adults and younger nonpregnant adults. Urinary tract infection and pneumonia are presentations more often encountered in elderly persons than in younger adults. The safety and immunogenicity of GBS serotype V-tetanus toxoid conjugate vaccine in healthy elderly persons suggest the potential for vaccination as an approach to prevention of invasive GBS infections in elderly persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI
Lancefield, R. C. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.57.4.571 · Cited by 1,341
Impaired Leucocyte Functions in Diabetic Patients
Delamaire, M., Maugendre, D., Moreno, M., Le Goff, M.-C., Allannic, H., & Genetet, B. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199701)14:1<29::aid-dia300>3.0.co;2-v · Cited by 1,074
Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis
Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., Lefkowitz, L. B., Hadler, J. L., Danila, R., Cieslak, P. R., & Schuchat, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420103 · Cited by 1,024
Clinical Relevance of Age-Related Immune Dysfunction
Castle, S. C. (2000) · Clinical Infectious Diseases · doi:10.1086/313947 · Cited by 640
Risk factors for erysipelas of the leg (cellulitis): case-control study
Dupuy, A., Benchikhi, H., Roujeau, J.-C., Bernard, P., Vaillant, L., Chosidow, O., Sassolas, B., Guillaume, J.-C., Grob, J.-J., & Bastuji-Garin, S. (1999) · BMJ · doi:10.1136/bmj.318.7198.1591 · Cited by 575
A Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant Adults
Farley, M. M., Harvey, C., Stull, T., Smith, J. D., Schuchat, A., Wenger, J. D., & Stephens, D. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282503 · Cited by 496
Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci
Eickhoff, T. C., Klein, J. O., Daly, A. K., Ingall, D., & Finland, M. (1964) · New England Journal of Medicine · doi:10.1056/nejm196412102712401 · Cited by 468
Group B Streptococcal Disease in Nonpregnant Adults
Farley, M. M. (2001) · Clinical Infectious Diseases · doi:10.1086/322696 · Cited by 451
Epidemiology and Unique Aspects of Aging and Infectious Diseases
Yoshikawa, T. T. (2000) · Clinical Infectious Diseases · doi:10.1086/313792 · Cited by 392
Schuchat, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07128-1 · Cited by 386
Cited by
Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005
Phares, C. R. (2008) · JAMA · doi:10.1001/jama.299.17.2056 · Cited by 878
Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007
Skoff, T. H., Farley, M. M., Petit, S., Craig, A. S., Schaffner, W., Gershman, K., Harrison, L. H., Lynfield, R., Mohle‐Boetani, J., Zansky, S., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/599369 · Cited by 452
Kline, K. A., & Lewis, A. L. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.uti-0012-2012 · Cited by 390
Group B Streptococcus: global incidence and vaccine development
Johri, A. K., Paoletti, L. C., Glaser, P., Dua, M., Sharma, P. K., Grandi, G., & Rappuoli, R. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1552 · Cited by 333
Group B Streptococcus ( Streptococcus agalactiae )
Raabe, V. N., & Shane, A. L. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0007-2018 · Cited by 330
Management of Infants at Risk for Group B Streptococcal Disease
Puopolo, K. M., Lynfield, R., Cummings, J. J., COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON INFECTIOUS DISEASES, Hand, I., Adams-Chapman, I., Poindexter, B., Stewart, D. L., Aucott, S. W., et al. (2019) · Pediatrics · doi:10.1542/peds.2019-1881 · Cited by 317
First Molecular Characterization of Group B Streptococci with Reduced Penicillin Susceptibility
Kimura, K., Suzuki, S., Wachino, J.-I., Kurokawa, H., Yamane, K., Shibata, N., Nagano, N., Kato, H., Shibayama, K., & Arakawa, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-08 · Cited by 306
Banerjee, A., Kim, B. J., Carmona, E. M., Cutting, A. S., Gurney, M. A., Carlos, C., Feuer, R., Prasadarao, N. V., & Doran, K. S. (2011) · Nature Communications · doi:10.1038/ncomms1474 · Cited by 142
Bacterial induction of Snail1 contributes to blood-brain barrier disruption
Kim, B. J., Hancock, B. M., Bermudez, A., Cid, N. D., Reyes, E., van Sorge, N. M., Lauth, X., Smurthwaite, C. A., Hilton, B. J., Stotland, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74159 · Cited by 145
Immunosenescence and vaccine failure in the elderly: strategies for improving response
Boraschi, D., & Italiani, P. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.06.006 · Cited by 86
Lewis, A. L., & Gilbert, N. M. (2020) · German Medical Science GMS Publishing House · doi:10.3205/id000046 · Cited by 79
“GBS is also frequently found in the urinary tract of people with diabetes, immunocompromised individuals, and thosewith pre-existing urologic abnormalities, all of whom are at increased risk of ascending pyelonephritis that can progress to bacteremia and/or urosepsis [44], [45].”
BackgroundMohammadi, N., Midiri, A., Mancuso, G., Patanè, F., Venza, M., Venza, I., Passantino, A., Galbo, R., Teti, G., Beninati, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160249 · Cited by 49
Metadata
- Authors
- High, K. P., Edwards, M. S., & Baker, C. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 839-847
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2130854755
- Cited by
- 383
- References
- 31
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.